February 5th, 2010

Podcast 73: How best to monitor patients on androgen-deprivation therapy for cardiovascular risks?

(2 votes, average: 4.00 out of 5)

A panel of the American Heart Association, the American Cancer Society, and the American Urological Association issued a statement on androgen-deprivation therapy and cardiovascular risk. We’ve got an interview with the chair of the writing committee, Dr. Glenn Levine.

Interview-related links:

News-related links:

If you’d like to contact Clinical Conversations, call 1-617-440-4374 or write to jelia@jwatch.org

Comments are closed.

Clinical Conversations

About the Podcast

To subscribe: Subscribe on iTunes

To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.